{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:15:41Z","timestamp":1793924141699,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T00:00:00Z","timestamp":1656806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T00:00:00Z","timestamp":1656806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["1R01LM013337"],"award-info":[{"award-number":["1R01LM013337"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG072449"],"award-info":[{"award-number":["RF1AG072449"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23HL151876"],"award-info":[{"award-number":["K23HL151876"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science Foundation United States","award":["1750326"],"award-info":[{"award-number":["1750326"]}],"id":[{"id":"https:\/\/ror.org\/021nxhr62","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis is a heterogeneous syndrome, and the identification of clinical subphenotypes is essential. Although organ dysfunction is a defining element of sepsis, subphenotypes of differential trajectory are not well studied. We sought to identify distinct Sequential Organ Failure Assessment (SOFA) score trajectory-based subphenotypes in sepsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We created 72-h SOFA score trajectories in patients with sepsis from four diverse intensive care unit (ICU) cohorts. We then used dynamic time warping (DTW) to compute heterogeneous SOFA trajectory similarities and hierarchical agglomerative clustering (HAC) to identify trajectory-based subphenotypes. Patient characteristics were compared between subphenotypes and a random forest model was developed to predict subphenotype membership at 6 and 24\u00a0h after being admitted to the ICU. The model was tested on three validation cohorts. Sensitivity analyses were performed with alternative clustering methodologies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 4678, 3665, 12,282, and 4804 unique sepsis patients were included in development and three validation cohorts, respectively. Four subphenotypes were identified in the development cohort: Rapidly Worsening (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009612, 13.1%), Delayed Worsening (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009960, 20.5%), Rapidly Improving (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091932, 41.3%), and Delayed Improving (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091174, 25.1%). Baseline characteristics, including the pattern of organ dysfunction, varied between subphenotypes. Rapidly Worsening was defined by a higher comorbidity burden, acidosis, and visceral organ dysfunction. Rapidly Improving was defined by vasopressor use without acidosis. Outcomes differed across the subphenotypes, Rapidly Worsening had the highest in-hospital mortality (28.3%,\n                      <jats:italic>P<\/jats:italic>\n                      -value\u2009&lt;\u20090.001), despite a lower SOFA (mean: 4.5) at ICU admission compared to Rapidly Improving (mortality:5.5%, mean SOFA: 5.5). An overall prediction accuracy of 0.78 (95% CI, [0.77, 0.8]) was obtained at 6\u00a0h after ICU admission, which increased to 0.87 (95% CI, [0.86, 0.88]) at 24\u00a0h. Similar subphenotypes were replicated in three validation cohorts. The majority of patients with sepsis have an improving phenotype with a lower mortality risk; however, they make up over 20% of all deaths due to their larger numbers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Four novel, clinically-defined, trajectory-based sepsis subphenotypes were identified and validated. Identifying trajectory-based subphenotypes has immediate implications for the powering and predictive enrichment of clinical trials. Understanding the pathophysiology of these differential trajectories may reveal unanticipated therapeutic targets and identify more precise populations and endpoints for clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-022-04071-4","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T03:02:21Z","timestamp":1656817341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Sepsis subphenotyping based on organ dysfunction trajectory"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhenxing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsheng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Siempos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa K.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Schenck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,3]]},"reference":[{"issue":"3","key":"4071_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1164\/rccm.201806-1197OC","volume":"200","author":"SV Bhavani","year":"2019","unstructured":"Bhavani SV, Carey KA, Gilbert ER, Afshar M, Verhoef PA, Churpek MM. Identifying novel sepsis subphenotypes using temperature trajectories. Am J Respir Crit Care Med. 2019;200(3):327\u201335.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"4071_CR2","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"13","key":"4071_CR3","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jama.2017.13836","volume":"318","author":"C Rhee","year":"2017","unstructured":"Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009\u20132014. JAMA. 2017;318(13):1241\u20139.","journal-title":"JAMA"},{"issue":"9805","key":"4071_CR4","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0140-6736(11)61761-3","volume":"378","author":"A Mullard","year":"2011","unstructured":"Mullard A. Drug withdrawal sends critical care specialists back to basics. Lancet. 2011;378(9805):1769.","journal-title":"Lancet."},{"issue":"20","key":"4071_CR5","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003\u201317.","journal-title":"JAMA"},{"issue":"5","key":"4071_CR6","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/CCM.0000000000004856","volume":"49","author":"E Abraham","year":"2021","unstructured":"Abraham E. Moving forward with refinement of definitions for sepsis. Crit Care Med. 2021;49(5):861\u20133.","journal-title":"Crit Care Med"},{"issue":"7","key":"4071_CR7","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S1473-3099(12)70136-6","volume":"12","author":"J Cohen","year":"2012","unstructured":"Cohen J, Opal S, Calandra T. Sepsis studies need new direction. Lancet Infect Dis. 2012;12(7):503\u20135.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"4071_CR8","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S1473-3099(15)70112-X","volume":"15","author":"J Cohen","year":"2015","unstructured":"Cohen J, Vincent JL, Adhikari NK, et al. Sepsis: a roadmap for future research. Lancet Infect Dis. 2015;15(5):581\u2013614.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"4071_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/CCM.0000000000004842","volume":"49","author":"KM DeMerle","year":"2021","unstructured":"DeMerle KM, Angus DC, Baillie JK, et al. Sepsis subclasses: a framework for development and interpretation. Crit Care Med. 2021;49(5):748\u201359.","journal-title":"Crit Care Med"},{"issue":"5","key":"4071_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s00134-015-3764-7","volume":"41","author":"DB Knox","year":"2015","unstructured":"Knox DB, Lanspa MJ, Kuttler KG, Brewer SC, Brown SM. Phenotypic clusters within sepsis-associated multiple organ dysfunction syndrome. Intens Care Med. 2015;41(5):814\u201322.","journal-title":"Intens Care Med"},{"issue":"10","key":"4071_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna BP, van Vught LA, Zwinderman AH, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Resp Med. 2017;5(10):816\u201326.","journal-title":"Lancet Resp Med"},{"issue":"6","key":"4071_CR12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/CCM.0000000000003084","volume":"46","author":"TE Sweeney","year":"2018","unstructured":"Sweeney TE, Azad TD, Donato M, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit Care Med. 2018;46(6):915\u201325.","journal-title":"Crit Care Med"},{"issue":"14","key":"4071_CR13","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","volume":"286","author":"FL Ferreira","year":"2001","unstructured":"Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA-J Am Med Assoc. 2001;286(14):1754\u20138.","journal-title":"JAMA-J Am Med Assoc"},{"issue":"6","key":"4071_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc11868","volume":"16","author":"Y Sakr","year":"2012","unstructured":"Sakr Y, Lobo SM, Moreno RP, et al. Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome. Crit Care. 2012;16(6):1\u20139.","journal-title":"Crit Care"},{"issue":"8","key":"4071_CR15","doi-asserted-by":"publisher","first-page":"e209271-e","DOI":"10.1001\/jamanetworkopen.2020.9271","volume":"3","author":"LN Sanchez-Pinto","year":"2020","unstructured":"Sanchez-Pinto LN, Stroup EK, Pendergrast T, Pinto N, Luo Y. Derivation and validation of novel phenotypes of multiple organ dysfunction syndrome in critically ill children. JAMA Network Open. 2020;3(8):e209271-e.","journal-title":"JAMA Network Open"},{"issue":"7","key":"4071_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. Intens Care Med. 1996;22(7):707\u201310.","journal-title":"Intens Care Med"},{"key":"4071_CR17","unstructured":"Berndt DJ, Clifford J. Using dynamic time warping to find patterns in time series. KDD workshop; 1994: Seattle, WA, USA; 1994. p. 359-70."},{"issue":"3","key":"4071_CR18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1145\/331499.331504","volume":"31","author":"AK Jain","year":"1999","unstructured":"Jain AK, Murty MN, Flynn PJ. Data clustering: a review. ACM Comput Surv. 1999;31(3):264\u2013323.","journal-title":"ACM Comput Surv"},{"key":"4071_CR19","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1038\/sdata.2016.35","volume":"3","author":"AEW Johnson","year":"2016","unstructured":"Johnson AEW, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. Sci Data. 2016;3:4458.","journal-title":"Sci Data"},{"issue":"4","key":"4071_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/cts.12294","volume":"8","author":"JB Starren","year":"2015","unstructured":"Starren JB, Winter AQ, Lloyd-Jones DM. Enabling a learning health system through a unified enterprise data warehouse: the experience of the northwestern university clinical and translational sciences (NUCATS) institute. Clin Transl Sci. 2015;8(4):269\u201371.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"4071_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sdata.2018.178","volume":"5","author":"TJ Pollard","year":"2018","unstructured":"Pollard TJ, Johnson AE, Raffa JD, Celi LA, Mark RG, Badawi O. The eICU collaborative research database, a freely available multi-center database for critical care research. Sci Data. 2018;5(1):1\u201313.","journal-title":"Sci Data"},{"key":"4071_CR22","doi-asserted-by":"publisher","first-page":"103789","DOI":"10.1016\/j.jbi.2021.103789","volume":"118","author":"EJ Schenck","year":"2021","unstructured":"Schenck EJ, Hoffman KL, Cusick M, Kabariti J, Sholle ET, Campion TR Jr. Critical carE Database for Advanced Research (CEDAR): An automated method to support intensive care units with electronic health record data. J Biomed Inform. 2021;118:103789.","journal-title":"J Biomed Inform"},{"issue":"1","key":"4071_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.32614\/RJ-2017-009","volume":"9","author":"S Moritz","year":"2017","unstructured":"Moritz S, Bartz-Beielstein T. imputeTS: time series missing value imputation in R. R J. 2017;9(1):207.","journal-title":"R J"},{"key":"4071_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338.","journal-title":"Annu Rev Clin Psychol"},{"key":"4071_CR25","unstructured":"Molnar C. Interpretable machine learning: Lulu.com; 2020."},{"issue":"11","key":"4071_CR26","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"HD Quan","year":"2005","unstructured":"Quan HD, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130\u20139.","journal-title":"Med Care"},{"issue":"3","key":"4071_CR27","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.chest.2018.09.031","volume":"155","author":"EJ Schenck","year":"2019","unstructured":"Schenck EJ, Oromendia C, Torres LK, Berlin DA, Choi AMK, Siempos II. Rapidly improving ARDS in therapeutic randomized controlled trials. Chest. 2019;155(3):474\u201382.","journal-title":"Chest"},{"issue":"4","key":"4071_CR28","first-page":"547","volume":"27","author":"EA Wo\u017anica","year":"2018","unstructured":"Wo\u017anica EA, Inglot M, Wo\u017anica RK. \u0141ysenko LJAic, University emooWM Liver dysfunction in sepsis. Science. 2018;27(4):547\u201351.","journal-title":"Science"},{"issue":"10235","key":"4071_CR29","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/S0140-6736(20)30531-6","volume":"395","author":"S Gaudry","year":"2020","unstructured":"Gaudry S, Hajage D, Benichou N, et al. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials. Lancet. 2020;395(10235):1506\u201315.","journal-title":"Lancet"},{"issue":"1","key":"4071_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-019-2663-7","volume":"23","author":"S Lambden","year":"2019","unstructured":"Lambden S, Laterre PF, Levy MM, Francois B. The SOFA score\u2014development, utility and challenges of accurate assessment in clinical trials. Crit Care. 2019;23(1):1\u20139.","journal-title":"Crit Care"},{"issue":"12","key":"4071_CR31","first-page":"1710","volume":"48","author":"D Abrams","year":"2020","unstructured":"Abrams D, Montesi SB, Moore SKL, et al. Powering bias and clinically important treatment effects in randomized trials of critical Illness. Science. 2020;48(12):1710\u20139.","journal-title":"Science"},{"issue":"1","key":"4071_CR32","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss RS, Moldawer LL, Opal SM, Reinhart K, Turnbull IR, Vincent J-L. Sepsis and septic shock. Nat Rev Dis Primers. 2016;2(1):16045.","journal-title":"Nat Rev Dis Primers"},{"issue":"13","key":"4071_CR33","first-page":"7789","volume":"3","author":"KC Ma","year":"2018","unstructured":"Ma KC, Schenck EJ, Siempos II, et al. Circulating RIPK3 levels are associated with mortality and organ failure during critical illness. Science. 2018;3(13):7789.","journal-title":"Science"},{"issue":"1","key":"4071_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-018-0218-0","volume":"26","author":"A Linkermann","year":"2019","unstructured":"Linkermann A. Death and fire\u2014the concept of necroinflammation. Cell Death Differ. 2019;26(1):1\u20133.","journal-title":"Cell Death Differ"},{"issue":"9","key":"4071_CR35","first-page":"7789","volume":"4","author":"EJ Schenck","year":"2019","unstructured":"Schenck EJ, Ma KC, Price DR, et al. Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis. Science. 2019;4(9):7789.","journal-title":"Science"},{"issue":"2","key":"4071_CR36","first-page":"253","volume":"45","author":"JC Mira","year":"2017","unstructured":"Mira JC, Gentile LF, Mathias BJ, et al. Sepsis pathophysiology, chronic critical Illness, and persistent inflammation-immunosuppression and catabolism syndrome. Science. 2017;45(2):253\u201362.","journal-title":"Science"},{"issue":"10","key":"4071_CR37","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41419-019-2015-1","volume":"10","author":"C Cao","year":"2019","unstructured":"Cao C, Yu M, Chai Y. Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis. Cell Death Dis. 2019;10(10):782.","journal-title":"Cell Death Dis"},{"key":"4071_CR38","first-page":"70002","volume":"5","author":"A Granholm","year":"2021","unstructured":"Granholm A, Alhazzani W, Derde LPG, et al. Randomised clinical trials in critical care: past, present and future. Intens Care Med. 2021;5:70002.","journal-title":"Intens Care Med."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-022-04071-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-022-04071-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T03:02:38Z","timestamp":1656817358000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-022-04071-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,3]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4071"],"URL":"https:\/\/doi.org\/10.1186\/s13054-022-04071-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.14.21258918","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,3]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent obtained for use of MIMIC-III, eICU, NMEDW, and CEDAR databases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ES received the consulting fees in terms of Axle Informatics (NIAID COVID19 Vaccine Subject Matter Expert Program) and payment in terms of Department of Defense (Peer Reviewed Medical Research Program). All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}